EirGenix (TPE:6589) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6589 EirGenix Inc TPE:6589
58 GF Score
Price NT$46.25
GF Value NT$93.18
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is EirGenix FFO per Share?

FFO per Share only applies to REITs.

TPE:6589
58GF Score
EirGenix Inc TPE:6589
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is EirGenix (TPE:6589) Overvalued in 2026?

Based on GuruFocus' analysis, EirGenix stock appears to be undervalued. The current stock price of NT$46.25 is trading 50.4% below its estimated GF Value™ of NT$93.18. GuruFocus considers EirGenix to be Possible Value Trap.

Key valuation signals for TPE:6589:

  • FFO per Share:
  • GF Value™: NT$93.18 vs. price of NT$46.25 (50.4% below fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the TPE:6589 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


EirGenix Business Description

Address No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180
EirGenix Inc is engaged in the research and development of biosimilars and new drugs, as well as biopharmaceutical contract development and manufacturing services, which included cell line construction platforms, process development platforms, analytical science and protein identification. Its products include CRM197 CARRIER PROTEIN, PRODUCT PIPELINE, COVID-19 ANTIGEN RAPID TEST. The revenue is derived from biopharmaceutical contract development and manufacturing services, sales of authorization and cooperative development, and sales of goods. Geographically, it operates in Japan, Taiwan, USA and Canada, Mainland China, Hong Kong, and Macao, and Europe, Others.
58GF Score

Get the complete analysis for TPE:6589

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$46.25
Price
NT$93.18
GF Value